- Home
- LAKE vs TLSI Comparison
LAKE vs TLSI Comparison
Compare LAKE & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAKE
- TLSI
- Stock Information
- Founded
- LAKE 1982
- TLSI 2010
- Country
- LAKE United States
- TLSI United States
- Employees
- LAKE N/A
- TLSI N/A
- Industry
- LAKE Industrial Specialties
- TLSI Medical Specialities
- Sector
- LAKE Health Care
- TLSI Health Care
- Exchange
- LAKE Nasdaq
- TLSI Nasdaq
- Market Cap
- LAKE 142.3M
- TLSI 150.0M
- IPO Year
- LAKE 1986
- TLSI N/A
- Fundamental
- Price
- LAKE $15.14
- TLSI $5.16
- Analyst Decision
- LAKE Strong Buy
- TLSI Strong Buy
- Analyst Count
- LAKE 3
- TLSI 5
- Target Price
- LAKE $26.00
- TLSI $10.90
- AVG Volume (30 Days)
- LAKE 81.9K
- TLSI 122.3K
- Earning Date
- LAKE 09-09-2025
- TLSI 08-12-2025
- Dividend Yield
- LAKE 0.80%
- TLSI N/A
- EPS Growth
- LAKE N/A
- TLSI N/A
- EPS
- LAKE N/A
- TLSI N/A
- Revenue
- LAKE $177,648,000.00
- TLSI $35,990,000.00
- Revenue This Year
- LAKE $32.98
- TLSI $56.79
- Revenue Next Year
- LAKE $4.70
- TLSI $54.15
- P/E Ratio
- LAKE N/A
- TLSI N/A
- Revenue Growth
- LAKE 34.28
- TLSI 45.50
- 52 Week Low
- LAKE $12.76
- TLSI $3.42
- 52 Week High
- LAKE $27.28
- TLSI $5.88
- Technical
- Relative Strength Index (RSI)
- LAKE 54.25
- TLSI 60.30
- Support Level
- LAKE $15.18
- TLSI $4.78
- Resistance Level
- LAKE $15.76
- TLSI $5.33
- Average True Range (ATR)
- LAKE 0.48
- TLSI 0.42
- MACD
- LAKE 0.03
- TLSI 0.10
- Stochastic Oscillator
- LAKE 58.11
- TLSI 90.81
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.